Vaccine
stringclasses 11
values | Dose
stringclasses 9
values | Geography Type
stringclasses 2
values | Geography
stringclasses 79
values | Birth Year/Birth Cohort
stringclasses 21
values | Dimension Type
stringclasses 6
values | Dimension
stringclasses 26
values | Estimate (%)
float64 4.7
100
⌀ | 95% CI (%)
stringlengths 10
13
⌀ | Sample Size
int64 9
63.4k
⌀ |
|---|---|---|---|---|---|---|---|---|---|
PCV | ≥2 Doses | States/Local Areas | New Hampshire | 2019-2020 | Age | 5 Months | 87.4 | 82.7 to 91.0 | 403 |
Hep B | ≥2 Doses | States/Local Areas | New Hampshire | 2019-2020 | Age | 5 Months | 93.6 | 90.3 to 95.8 | 403 |
Hib | Primary Series | States/Local Areas | New Hampshire | 2019-2020 | Age | 13 Months | 93 | 89.4 to 95.4 | 403 |
Hep B | ≥2 Doses | States/Local Areas | New Hampshire | 2019-2020 | Age | 13 Months | 96 | 93.2 to 97.7 | 403 |
Hib | ≥2 Doses | States/Local Areas | New Hampshire | 2019-2020 | Age | 13 Months | 96.5 | 93.7 to 98.1 | 403 |
Hib | ≥3 Doses | States/Local Areas | New Hampshire | 2019-2020 | Age | 13 Months | 92.7 | 89.1 to 95.2 | 403 |
≥1 Dose MMR | null | States/Local Areas | New Hampshire | 2019-2020 | Age | 13 Months | 69.3 | 63.4 to 74.6 | 403 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2019-2020 | Age | 19 Months | 79.6 | 74.3 to 84.1 | 403 |
Hib | ≥1 Dose | States/Local Areas | New Hampshire | 2019-2020 | Age | 3 Months | 92 | 88.2 to 94.7 | 403 |
DTaP | ≥1 Dose | States/Local Areas | New Hampshire | 2019-2020 | Age | 3 Months | 92.9 | 89.2 to 95.4 | 403 |
Polio | ≥1 Dose | States/Local Areas | New Hampshire | 2019-2020 | Age | 3 Months | 92.2 | 88.3 to 94.8 | 403 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2019-2020 | Age | 13 Months | 93.5 | 90.2 to 95.8 | 403 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2019-2020 | Age | 7 Months | 76.3 | 70.6 to 81.1 | 403 |
Hib | Primary Series | States/Local Areas | New Hampshire | 2019-2020 | Age | 7 Months | 78.9 | 73.3 to 83.5 | 403 |
Polio | ≥3 Doses | States/Local Areas | New Hampshire | 2019-2020 | Age | 19 Months | 95.2 | 92.2 to 97.1 | 403 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 35 Months | 95.8 | 89.4 to 98.9 | 126 |
Hib | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 7 Months | 73.4 | 62.9 to 81.8 | 126 |
Hib | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 19 Months | 89.2 | 79.8 to 94.5 | 126 |
Hib | Primary Series | States/Local Areas | New Hampshire | 2020-2021 | Age | 24 Months | 94.3 | 90.3 to 97.0 | 315 |
Combined 7 Series | null | States/Local Areas | New Hampshire | 2016-2019 | Insurance Coverage | Any Medicaid | 74.9 | 68.7 to 81.1 | 275 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Insurance Coverage | Any Medicaid | 93.3 | 89.3 to 97.4 | 275 |
Influenza | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 77.7 | 72.2 to 83.2 | 394 |
PCV | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 75.2 | 66.5 to 83.8 | 159 |
Hep A | ≥1 Dose | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 94.1 | 91.3 to 96.9 | 394 |
Hib | Full Series | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 74.9 | 66.3 to 83.6 | 159 |
Hib | Full Series | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 88.2 | 83.9 to 92.4 | 335 |
Hib | Full Series | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 88.5 | 84.3 to 92.8 | 394 |
Polio | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 86.4 | 79.1 to 93.7 | 159 |
≥1 Dose MMR | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 89.6 | 83.3 to 95.9 | 159 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 87.5 | 83.2 to 91.8 | 335 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 90.4 | 86.8 to 94.0 | 394 |
≥1 Dose Varicella | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 90.2 | 84.3 to 96.1 | 159 |
≥1 Dose Varicella | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 89.9 | 85.6 to 94.2 | 335 |
≥1 Dose Varicella | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 95.9 | 93.5 to 98.2 | 394 |
Influenza | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 65.7 | 56.8 to 74.6 | 159 |
Influenza | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 68.6 | 62.5 to 74.7 | 335 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 94.3 | 92.3 to 96.3 | 888 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 95.2 | 93.2 to 97.1 | 888 |
≥1 Dose MMR | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 94.1 | 91.1 to 97.1 | 335 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 87.3 | 80.1 to 94.4 | 159 |
≥1 Dose MMR | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 96.9 | 95.2 to 98.7 | 394 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 65.4 | 54.8 to 76.1 | 159 |
Hep B | ≥1 Dose, 3 Day (Birth Dose) | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 80.6 | 75.5 to 85.6 | 335 |
Hep B | ≥1 Dose, 3 Day (Birth Dose) | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 78.6 | 73.4 to 83.7 | 394 |
PCV | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 89.9 | 86.2 to 93.6 | 335 |
PCV | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 92.4 | 89.0 to 95.8 | 394 |
≥1 Dose Varicella | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 90.1 | 83.6 to 96.5 | 165 |
Rotavirus | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 73.1 | 64.5 to 81.6 | 159 |
Rotavirus | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 82.9 | 78.0 to 87.9 | 335 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 85.5 | 78.0 to 93.1 | 165 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 94.2 | 90.9 to 97.5 | 339 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 96.8 | 94.7 to 98.8 | 384 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 95.8 | 93.2 to 98.4 | 339 |
≥1 Dose Varicella | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 94.3 | 91.6 to 97.1 | 384 |
PCV | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 87.9 | 83.3 to 92.4 | 339 |
PCV | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 91.9 | 88.7 to 95.0 | 384 |
Influenza | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 62.8 | 53.7 to 71.9 | 165 |
Combined 7 Series | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 76.2 | 70.3 to 82.1 | 339 |
Combined 7 Series | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 79.1 | 74.2 to 84.1 | 384 |
Influenza | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 76.4 | 71.2 to 81.6 | 384 |
Rotavirus | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 89.6 | 86.0 to 93.1 | 384 |
Rotavirus | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 78.1 | 69.8 to 86.5 | 165 |
Hep A | ≥1 Dose | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 87 | 80.2 to 93.9 | 165 |
Hep A | ≥1 Dose | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 88.1 | 84.0 to 92.3 | 339 |
Hep A | ≥1 Dose | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 92.5 | 89.5 to 95.4 | 384 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 78.9 | 71.5 to 86.2 | 339 |
Hib | Full Series | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 81.9 | 73.9 to 89.9 | 165 |
Hib | Full Series | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 87 | 82.3 to 91.7 | 339 |
Hib | Full Series | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 86.1 | 81.9 to 90.4 | 384 |
≥1 Dose MMR | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 95.9 | 93.6 to 98.1 | 384 |
Rotavirus | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 82.4 | 77.1 to 87.6 | 339 |
≥1 Dose MMR | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 95.7 | 93.5 to 97.9 | 339 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 80.9 | 71.9 to 89.9 | 165 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 87 | 79.6 to 94.4 | 165 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 85.6 | 80.8 to 90.3 | 339 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 97.9 | 96.3 to 99.5 | 384 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 96.2 | 93.5 to 98.9 | 339 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 79.5 | 71.2 to 87.7 | 165 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 89.8 | 86.3 to 93.2 | 384 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 88.9 | 82.2 to 95.6 | 165 |
Influenza | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 71.4 | 65.0 to 77.7 | 339 |
Polio | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 85.5 | 77.9 to 93.1 | 165 |
Polio | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 97.5 | 95.9 to 99.2 | 384 |
Polio | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 96.2 | 93.5 to 98.9 | 339 |
Combined 7 Series | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 72.2 | 63.5 to 81.0 | 165 |
Hep B | ≥1 Dose, 3 Day (Birth Dose) | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 81.4 | 76.1 to 86.7 | 339 |
Combined 7 Series | null | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 76.7 | 73.2 to 80.3 | 888 |
Polio | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 96 | 93.4 to 98.6 | 335 |
Polio | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 97.5 | 95.6 to 99.4 | 394 |
≥1 Dose Varicella | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a Non-MSA | 91.4 | 87.5 to 95.3 | 339 |
Hep B | ≥1 Dose, 3 Day (Birth Dose) | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 79.4 | 74.5 to 84.3 | 384 |
Hep B | ≥1 Dose, 3 Day (Birth Dose) | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 78 | 70.0 to 86.0 | 165 |
Hib | Full Series | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 85.7 | 82.6 to 88.7 | 888 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 94.8 | 91.9 to 97.7 | 335 |
Hep B | ≥1 Dose, 3 Day (Birth Dose) | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 81.1 | 73.4 to 88.8 | 159 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 96.4 | 93.9 to 99.0 | 394 |
Combined 7 Series | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 66.2 | 56.9 to 75.4 | 159 |
Combined 7 Series | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 80.7 | 75.7 to 85.7 | 394 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 96.5 | 94.1 to 99.0 | 335 |
Combined 7 Series | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 77.9 | 72.5 to 83.4 | 335 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.